Pfizer CEO Albert Bourla said there is “quite a good chance” the team testing his company’s vaccine candidate for Covid-19 will know whether it works by the end of October.
“In our best case, we have quite a good chance, more than 60%, that we will know if the product works or not by the end of October,” he said on CBS today. “But of course, that doesn’t mean that it works. It means that we will know if it works.”
When asked whether people would have to wait until 2021 to receive the vaccine, Bourla said that he didn’t know how long it would take for regulators to approve the drug.
“We have a good chance that we will know if the product works by the end of October. Then, of course, it is (the) regulator’s job to issue (a) license or not," he said.
Pfizer has started manufacturing the vaccine and Bourla said hundreds of thousands of doses have already been made.
More details: Bourla said vaccine distribution will be a problem. Shipping medicines is complex, particularly when they need special storage conditions. But he said Pfizer already knows how to do it very well.
As for who gets the vaccine, Bourla said that is something the authorities should decide, for example, the US Centers for Disease Control and Prevention.